Treatment of Anal Fistulas With Obsidian RFT®

计划入组 18 人 · 首次发布于 2023 年 11 月 18 日

Impact of Obsidian ® ASG on Anastomotic Healing

计划入组 270 人 · 首次发布于 2020 年 5 月 13 日

EMDR on Pain in Patients With in Patients Rheumatoid Arthritis

计划入组 64 人 · 首次发布于 2023 年 7 月 13 日

mbIL15-BCMA CAR-T

Tumour infiltrating lymphocyte therapy (Cellular Therapeutics (Obsidian Therapeutics)

TIL engineered with regulatable mbIL15 and LIGHT (Obsidian)

Obsidian Therapeutics, Inc.

United States

JASPER THERAPEUTICS, INC

United States

CRISPR Therapeutics, Inc.

United States

Obsidian and Galera Therapeutics Announce $350 Million Merger to Advance Next-Generation TIL Cell Therapy

Obsidian Therapeutics Enrolls First Patient in Registration-Enabling Cohort for Amsoki-cel TIL Therapy in Advanced Melanoma

Tumor-Infiltrating Lymphocyte Therapy Market Poised for Explosive Growth Following First FDA Approval